← Back to catalogue

Phosphoplastin RL

FDA 510(k)FDA UDIEUDAMED

Class II (US FDA 510(k))

510(k) K040296Ref 11-310Ref 11-305

by R2 Diagnostics, Inc.

Identity

Trade Name
Phosphoplastin RL EUDAMEDFDA UDI
Generic Name
Prothrombin time (PT) IVD, reagent FDA UDI
Device Name
Phosphoplastin RL EUDAMED
PT reagent 10 x 5 ml FDA UDI
PT reagent 10 x 10 ml FDA UDI
Model / Reference
11-305 EUDAMEDFDA UDI
11-310 EUDAMEDFDA UDI
Description
PT reagent 10 x 5 ml FDA UDI
PT reagent 10 x 10 ml FDA UDI

Identifiers

Catalog Number
11-305 FDA UDI
11-310 FDA UDI
Primary DI / UDI-DI
10859394006023 EUDAMEDFDA UDI
10859394006030 EUDAMEDFDA UDI
Basic UDI-DI
B-10859394006030 EUDAMED
B-10859394006023 EUDAMED
510(k) Number
K040296 FDA 510(k)FDA UDI
FDA Product Code
GJS FDA 510(k)FDA UDI
EMDN Code
W0103020101 PROTHROMBIN TIME ( QUICK TEST ) EUDAMED
GMDN Term
Prothrombin time (PT) IVD, reagent FDA UDI

Classification

Device Class
Class IVD General EUDAMED
Class II FDA 510(k)FDA UDI
Legislation / Framework
21 CFR Part 864.7750 FDA 510(k)
Regulation Number
864.7750 FDA 510(k)FDA UDI
Market of Registration
Italy EUDAMED
Advisory Committee
Hematology FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

EUDAMEDFDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMEDEUDAMED

Microbial Substances

No

EUDAMED

Reagent

Yes

EUDAMED

Self Testing

No

EUDAMED

Near-Patient Testing

No

EUDAMED

Professional Testing

Yes

EUDAMED

Companion Diagnostics

No

EUDAMED

Surgical Instrument

No

EUDAMED

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Phosphoplastin RL is a liquid thromboplastin reagent used in the one-stage prothrombin time (PT) test, a critical in vitro diagnostic assay for assessing coagulation function. It is designed for extrinsic factor assays and therapeutic monitoring of anticoagulant drugs such as Warfarin, enabling clinicians to evaluate coagulopathies and monitor hemostasis.

The device is supplied as a liquid reagent intended for single-use in clinical coagulation laboratories. It is classified as a Class II medical device under FDA regulations (864.7750) and has received both FDA 510(k) clearance and In Vitro Diagnostic Device (IVDD) authorization. Storage and handling conditions are not specified in the provided data, but standard laboratory practices for sensitive reagents should be followed.

Frequently asked questions

What clinical applications is Phosphoplastin RL primarily used for in a laboratory setting?

Phosphoplastin RL is specifically designed for the one-stage prothrombin time (PT) test, which evaluates coagulation function by measuring the time it takes for blood to clot. It is used for extrinsic factor assays and therapeutic monitoring of anticoagulant drugs like Warfarin, helping clinicians assess coagulopathies and monitor hemostasis.

Is Phosphoplastin RL intended for single-use or repeated use in a clinical setting?

Phosphoplastin RL is supplied as a liquid reagent explicitly intended for single-use in clinical coagulation laboratories. This ensures consistency and reliability in test results, as reuse could compromise sterility and accuracy.

What regulatory pathways has Phosphoplastin RL undergone, and what does that mean for its use?

Phosphoplastin RL has received both FDA 510(k) clearance and In Vitro Diagnostic Device (IVDD) authorization, confirming it meets regulatory standards for safety and performance. The device is classified as a Class II medical device under FDA regulations (864.7750), indicating it has undergone rigorous review by the Hematology (HE) advisory committee.

How is Phosphoplastin RL supplied, and what should be considered when handling it?

Phosphoplastin RL is supplied as a liquid reagent, intended for use in clinical coagulation laboratories. While specific storage conditions aren’t detailed, standard laboratory practices for sensitive reagents—such as protecting from light, contamination, and extreme temperatures—should be followed to maintain its integrity and ensure accurate test results.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Phosphoplastin RL - r² Diagnostics, Home - r² Diagnostics, PHOSPHOPLASTIN RL (K040296) — FDA 510 (k) | Innolitics

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

IVDD

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (5)

  • FDA 510(k) K040296 24 fields · synced Sep 18, 2026
  • FDA UDI 83071d2c-a7ad-44b9-9898-0c8e7f296da1 35 fields · synced May 29, 2026
  • FDA UDI 34333a9d-95bc-4750-82b4-9fbc5ee2fe4c 35 fields · synced May 30, 2026
  • EUDAMED 1afcea3d-ff86-4154-8e08-4abfe8ede3f6 61 fields · synced Jun 20, 2026
  • EUDAMED bc1f6d97-994d-4579-99eb-8aae44b8b0a7 61 fields · synced Jul 10, 2026